The Doctors Company has completed its $1.3 billion cash acquisition of ProAssurance, paying $25 per share to take the specialty insurer private and delist its common stock. The combined entity will hold $12 billion in assets and serve over 200,000 healthcare professionals and organizations nationwide.
The Doctors Company finalized a cash acquisition of ProAssurance, acquiring all outstanding shares at $25 per share for a total cost of approximately $1.3 billion. ProAssurance’s common stock has been deregistered with the SEC and delisted from the NYSE, and public trading has ceased.
Post-merger, the combined group will manage $12 billion in assets and provide coverage to more than 200,000 healthcare professionals and organizations across the United States. ProAssurance will operate as a wholly owned subsidiary while a review determines the optimal operating structure.
The acquisition aims to create the largest physician-owned medical malpractice and specialty lines insurer in America, with enhanced expertise in medical liability, products liability, and workers’ compensation. The integration is expected to strengthen long-term stability and expand advocacy efforts across all 50 states.
